Omada Health (OMDA) Stock Forecast, Price Target & Predictions
OMDA Stock Forecast
Omada Health (OMDA) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $24.67, with a high of $32.00 and a low of $17.00. This represents a 107.49% increase from the last price of $11.89.
OMDA Stock Rating
Omada Health stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
OMDA Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Omada Health | 107.49% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Healthcare Information Services Stocks | 45.21% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 5 | 8 |
| Avg Price Target | - | $25.20 | $25.00 |
| Last Closing Price | $11.89 | $11.89 | $11.89 |
| Upside/Downside | - | 111.94% | 110.26% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Feb, 26 | 4 | 5 | 2 | - | - | 11 |
| Jan, 26 | 4 | 5 | 1 | - | - | 10 |
| Dec, 25 | 4 | 5 | 1 | - | - | 10 |
| Nov, 25 | 4 | 4 | 1 | - | - | 9 |
| Oct, 25 | 4 | 4 | 1 | - | - | 9 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jan 16, 2026 | David Roman | Goldman Sachs | $26.00 | $15.65 | 66.13% | 118.67% |
| Jan 09, 2026 | Goldman Sachs | $29.00 | $16.44 | 76.40% | 143.90% | |
| Jan 08, 2026 | Wells Fargo | $17.00 | $16.44 | 3.41% | 42.98% | |
| Jan 05, 2026 | Saket Kalia | Barclays | $22.00 | $14.90 | 47.65% | 85.03% |
| Dec 18, 2025 | Morgan Stanley | $32.00 | $14.62 | 118.88% | 169.13% | |
| Oct 08, 2025 | Elizabeth Anderson | Evercore ISI | $27.00 | $25.00 | 8.00% | 127.08% |
| Sep 05, 2025 | Robert W. Baird | $24.00 | $24.28 | -1.15% | 101.85% | |
| Jul 01, 2025 | Needham | $23.00 | $18.25 | 26.03% | 93.44% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jan 16, 2026 | Goldman Sachs | Buy | Buy | hold |
| Jan 05, 2026 | Barclays | Overweight | Overweight | hold |
| Oct 22, 2025 | Barclays | Overweight | Overweight | hold |
| Jul 01, 2025 | Needham | Buy | initialise |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | - | - | - | - |
| Avg Forecast | $-4.76 | $-0.38 | $-0.13 | $0.08 |
| High Forecast | $-4.68 | $-0.38 | $-0.11 | $0.44 |
| Low Forecast | $-4.81 | $-0.38 | $-0.15 | $-0.12 |
| Surprise % | - | - | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $169.80M | - | - | - |
| Avg Forecast | $189.67M | $238.91M | $266.36M | $343.97M |
| High Forecast | $191.35M | $240.90M | $266.39M | $347.03M |
| Low Forecast | $187.40M | $236.00M | $266.32M | $339.85M |
| Surprise % | -10.48% | - | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-47.14M | - | - | - |
| Avg Forecast | $-264.62M | $-21.29M | $-7.25M | $-756.24K |
| High Forecast | $-261.02M | $-21.18M | $-6.13M | $24.73M |
| Low Forecast | $-268.21M | $-21.40M | $-8.36M | $-6.69M |
| Surprise % | -82.19% | - | - | - |